Metastatic Disease clinical trials

Explore recruiting metastatic disease clinical trials.

Recruiting metastatic disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Metastatic Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A First in human, Phase 1/2a, Multicentre, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of PBP1510 in Patients with Advanced/Metastatic Pancreatic Cancer

Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A phase II prospective, open-label, multi-centre, single arm study of sasanlimab plus sacituzumab govitecan in BCG (Bacillus Calmette-Guérin)- unresponsive non-muscle invasive bladder cancer (NMIBC) patients.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Neoadjuvant Immunotherapy and Organ-sparing Treatment in Patients with Stage I-III dMMR Colon Cancer: A National, Multicentre, Personalised, Phase II Study (RESET C2)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Total Neoadjuvant Therapy for lymph node-positive adenocarcinoma of the OESophagus and oesophagogastric junction: TNT-OES-2 trial

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

L-UteCIN : Interest of adjuvant chemotherapy in patients with CINSARC high-risk localized resected uterine leiomyosarcoma

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Interest of peri operative CHemotherapy In patients with CINSARC high-risk localized Soft Tissue Sarcoma

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Metastatic Disease trials by city

Metastatic Disease in Toronto Metastatic Disease in Vancouver Metastatic Disease in Montreal Metastatic Disease in Calgary Metastatic Disease in Edmonton Metastatic Disease in Ottawa Metastatic Disease in Winnipeg Metastatic Disease in Quebec City Metastatic Disease in Hamilton Metastatic Disease in Kitchener Metastatic Disease in London Metastatic Disease in Halifax Metastatic Disease in New York Metastatic Disease in Los Angeles Metastatic Disease in Chicago Metastatic Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease